强生公司近日宣布,将以每股335.00美元,总计约131亿美元收购心血管设备制造商Shockwave Medical,此举旨在借助Shockwave的血管内碎石技术,加强其在医疗科技领域的影响力。强生计划通过现金和债务筹集资金,预计交易将于2024年中完成。尽管收购初期可能导致公司2024年和2025年的每股收益分别减少约0.10美元和约0.17美元,但长期来看...
What's Next for Johnson & Johnson Stock Amid Shockwave Medical Deal? Let's examine the charts of the healthcare giant. JNJSWAV Trade Ideas Mar 27, 2024 1:11 PM EDT Shockwave Medical Soars as J&J Is in Talks to Buy the Firm A deal could happen soon but other suitors could jump in....